Once word gets out about omontys and providers and patients realize the advantages and start requesting this drug Davita will be stuck with their exclusive Amgen contract. Fresenius and other clinics were smart to leave their options open and will reap the benefits of this pharmaceutical breakthrough. Only a matter of time......
Ridiculous statement. The idea that any business would tie its future to one supplier is stupid.
Davita does not require patients to use Amgen. Doctors decide which medications patients use. If a patient is prescribed Omontys, Davita uses Omontys. Davita has a supply agreement but is not required to refuse treatments to patients that use non-recommended products.
"Doctors decide which medications patients use" And if a patient is on dialysis and inevitably has anemia what are the medication choices in the US? Epogen or Omontys. Davita's supply agreement with Amgen is 90% Exclusive. Only Epogen can be used at Davita clinics. For this exclusive agreement Davita receives a deep discount to the price of Epogen. Until this contract expires Davita cannot supply their patients with Omontys or they will violate this contract.
My point is this, when doctors and patients fully realize the benefits (health and financial) of a once a month injection vesus 13 injections, Davita will be tied to their exclusive with Amgen and as a result may lose patients and Dr. referrals.